Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Galecto stock | $3.4

Learn how to easily invest in Galecto stock.

Galecto Inc
- $0.11 ( - 3.13%)

Galecto Inc is a biotechnology business based in the US. Galecto shares (GLTO) are listed on the NASDAQ and all prices are listed in US Dollars. Galecto employs 28 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Galecto

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GLTO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Galecto stock price (NASDAQ: GLTO)

Use our graph to track the performance of GLTO stocks over time.

Galecto shares at a glance

Information last updated 2021-10-17.
Latest market close$3.40
52-week range$3.34 - $17.99
50-day moving average $3.90
200-day moving average $4.75
Wall St. target price$13.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.86

Buy Galecto shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Galecto stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Galecto price performance over time

Historical closes compared with the close of $3.4 from 2021-10-22

1 week (2021-10-15) -0.58%
1 month (2021-09-24) -11.69%
3 months (2021-07-23) -22.73%
6 months (2021-04-23) -43.33%
1 year (2020-10-21) N/A
2 years (2019-10-21) N/A
3 years (2018-10-21) N/A
5 years (2016-10-21) N/A

Galecto financials

Gross profit TTM $0
Return on assets TTM -31.48%
Return on equity TTM -54.76%
Profit margin 0%
Book value $5.60
Market capitalisation $86.4 million

TTM: trailing 12 months

Shorting Galecto shares

There are currently 48,291 Galecto shares held short by investors – that's known as Galecto's "short interest". This figure is 41.9% down from 83,176 last month.

There are a few different ways that this level of interest in shorting Galecto shares can be evaluated.

Galecto's "short interest ratio" (SIR)

Galecto's "short interest ratio" (SIR) is the quantity of Galecto shares currently shorted divided by the average quantity of Galecto shares traded daily (recently around 86233.928571429). Galecto's SIR currently stands at 0.56. In other words for every 100,000 Galecto shares traded daily on the market, roughly 560 shares are currently held short.

To gain some more context, you can compare Galecto's short interest ratio against those of similar companies.

However Galecto's short interest can also be evaluated against the total number of Galecto shares, or, against the total number of tradable Galecto shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Galecto's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Galecto shares in existence, roughly 0 shares are currently held short) or 0.0039% of the tradable shares (for every 100,000 tradable Galecto shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Galecto.

Find out more about how you can short Galecto stock.

Galecto share dividends

We're not expecting Galecto to pay a dividend over the next 12 months.

You may also wish to consider:

Galecto overview

Galecto, Inc. , a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. .

Frequently asked questions

What percentage of Galecto is owned by insiders or institutions?
Currently 11.418% of Galecto shares are held by insiders and 51.422% by institutions.
How many people work for Galecto?
Latest data suggests 28 work at Galecto.
When does the fiscal year end for Galecto?
Galecto's fiscal year ends in December.
Where is Galecto based?
Galecto's address is: 75 State Street, Boston, MA, United States, 02109
What is Galecto's ISIN number?
Galecto's international securities identification number is: US36322Q1076

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site